{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T11:29:54Z","timestamp":1768649394606,"version":"3.49.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1097\/inf.0000000000000441","type":"journal-article","created":{"date-parts":[[2014,6,7]],"date-time":"2014-06-07T12:39:37Z","timestamp":1402144777000},"page":"e299-e304","source":"Crossref","is-referenced-by-count":30,"title":["Impact of Rotavirus Vaccination in Germany"],"prefix":"10.1097","volume":"33","author":[{"given":"Ulrike","family":"Uhlig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibylle","family":"Koletzko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holm H.","family":"Uhlig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"suppl 5","key":"R2-18-20210202","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1469-0691.2012.03981.x","article-title":"Rotavirus vaccination: a concise review.","volume":"18","author":"Vesikari","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"R4-18-20210202","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00103-013-1777-3","article-title":"Background paper to the recommendation for routine rotavirus vaccination of infants in Germany.","volume":"56","author":"Koch","year":"2013","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"R6-18-20210202","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1097\/INF.0b013e31822d1408","article-title":"Rotavirus vaccination in Germany: analysis of nationwide surveillance data 2006 to 2010.","volume":"30","author":"Uhlig","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R7-18-20210202","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.4161\/hv.21593","article-title":"Impact of rotavirus vaccination in regions with low and moderate vaccine uptake in Germany.","volume":"8","author":"Dudareva-Vizule","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"R8-18-20210202","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3201\/eid1310.070253","article-title":"SurvNet electronic surveillance system for infectious disease outbreaks, Germany.","volume":"13","author":"Krause","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"R9-18-20210202","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/INF.0b013e3181f1eb21","article-title":"Epidemiology of rotavirus infections in children less than 5 years of age: Germany, 2001-2008.","volume":"30","author":"Koch","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R10-18-20210202","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5414\/CPP47617","article-title":"Validity and representativeness of the Disease Analyzer patient database for use in pharmacoepidemiological and pharmacoeconomic studies.","volume":"47","author":"Becher","year":"2009","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R11-18-20210202","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00431-011-1536-0","article-title":"Complications in hospitalized children with acute gastroenteritis caused by rotavirus: a retrospective analysis.","volume":"171","author":"Kaiser","year":"2012","journal-title":"Eur J Pediatr"},{"key":"R12-18-20210202","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1097\/INF.0b013e3182720b71","article-title":"Rotavirus vaccine effectiveness and case-control study on risk factors for breakthrough infections in Germany, 2010-2011.","volume":"32","author":"Adlhoch","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R14-18-20210202","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1476-072X-11-37","article-title":"Ecological analysis of social risk factors for rotavirus infections in Berlin, Germany, 2007-2009.","volume":"11","author":"Wilking","year":"2012","journal-title":"Int J Health Geogr"},{"key":"R15-18-20210202","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.1172330","article-title":"Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics.","volume":"325","author":"Pitzer","year":"2009","journal-title":"Science"},{"key":"R16-18-20210202","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Rotavirus Intussusception Investigation Team. Intussusception among infants given an oral rotavirus vaccine.","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"key":"R17-18-20210202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/INF.0b013e3182421390","article-title":"Postmarketing evaluation of the short-term safety of the pentavalent rotavirus vaccine.","volume":"31","author":"Loughlin","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"R18-18-20210202","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1001\/jama.2012.97","article-title":"Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.","volume":"307","author":"Shui","year":"2012","journal-title":"JAMA"},{"key":"R19-18-20210202","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil.","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"R21-18-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"key":"R22-18-20210202","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"R23-18-20210202","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/INF.0b013e3181fefdee","article-title":"Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australias National Childhood vaccine schedule.","volume":"30","author":"Buttery","year":"2011","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:04:26Z","timestamp":1620954266000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201411000-00018"}},"subtitle":["Rotavirus Surveillance, Hospitalization, Side Effects and Comparison of Vaccines"],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000441","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}